Significados de ovarian neoplasms em inglês

The expression of ST-3 has not been systematically studied in ovarian neoplasms.

Objective: Some forms of ovarian neoplasms may be preventable through the removal of precursor lesions.

Epithelial ovarian neoplasms can be divided into three distinct clinicopathological groups: benign, malignant and borderline tumours.

Dysgerminomas make up two thirds of all malignant ovarian neoplasms in women younger than 20 years.

Thirty-seven patients with epithelial ovarian cancer and 14 patients with benign ovarian neoplasms completed psychosocial questionnaires pre-surgery.

Conclusion: Intraoperative rupture of malignant epithelial ovarian neoplasms may worsen the prognosis of patients with stage I ovarian cancer.

EGF-R expression was found to be increased in 40% of malignant epithelial ovarian neoplasms by an immunohistochemical method.

In the typical case, the distinction between sex cord-stromal and other ovarian neoplasms requires nothing more than routine pathological examination.

The benign tumors in Meigs syndrome are usually fibromas or fibrothecomas and constitute 4% of all ovarian neoplasms.

We conclude that detection of basement membrane components may be useful in recognizing early invasion in this group of ovarian neoplasms.

This investigation hypothesizes that inhibin immunohistochemistry will aid in the crucial clinical distinction between sex cord-stromal and other primary ovarian neoplasms.

No novel significant associations were identified between LOH events and stage, grade, or histology, which would indicate the existence of genetic heterogeneity in ovarian neoplasms.

We have previously reported LOH on 9p in 45% of malignant ovarian neoplasms and a smaller percentage of benign and LMP tumours.

Ovarian neoplasms are common in women of all ages.